Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism

Nature Genetics

Volumn 45, Issue 9, 2013, Pages 1050-1054

  Scholl, Ute I ^a   Goh, Gerald ^a   Stölting, Gabriel ^b   De Oliveira, Regina Campos ^c   Choi, Murim ^a   Overton, John D ^a   Fonseca, Annabelle L ^a   Korah, Reju ^a   Starker, Lee F ^a,d   Kunstman, John W ^a   Prasad, Manju L ^a   Hartung, Erum A ^e   Mauras, Nelly ^f   Benson, Matthew R ^f   Brady, Tammy ^g   Shapiro, Jay R ^h   Loring, Erin ^a   Nelson Williams, Carol ^a   Libutti, Steven K ⁱ   Mane, Shrikant ^a   Hellman, Per ^d   Westin, Gunnar ^d   Åkerström, Göran ^d   Björklund, Peyman ^d   Carling, Tobias ^a,j   Fahlke, Christoph ^b   Hidalgo, Patricia ^b   Lifton, Richard P ^a   more..

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FORSCHUNGSZENTRUM JÜLICH   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d UPPSALA UNIVERSITY   (Sweden)

^e CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^f NEMOURS CHILDREN S CLINIC   (United States)

^g JOHNS HOPKINS UNIVERSITY   (United States)

^h KENNEDY KRIEGER INSTITUTE   (United States)

ⁱ ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^j YALE CANCER CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

VOLTAGE GATED CALCIUM CHANNEL; ALDOSTERONE; CACNA1D PROTEIN, HUMAN; CALCIUM CHANNEL L TYPE;

ADRENAL CORTEX; ADRENAL HYPERPLASIA; ALDOSTERONE RELEASE; ARTICLE; BLOOD PRESSURE; CACNA1D GENE; CALCIUM TRANSPORT; CELL PROLIFERATION; CEREBRAL BLINDNESS; FAMILIAL HEMIPLEGIC MIGRAINE; FAMILY HISTORY; GAIN OF FUNCTION MUTATION; GENE; GLOMERULOSA CELL; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INTELLECTUAL IMPAIRMENT; MEMBRANE POTENTIAL; NIGHT BLINDNESS; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SHORT TANDEM REPEAT; SOMATIC MUTATION; TONIC CLONIC SEIZURE; ZONA GLOMERULOSA; ADRENAL CORTEX ADENOMA; ADRENAL CORTEX TUMOR; AMINO ACID SEQUENCE; BIOSYNTHESIS; CELL LINE; CHEMISTRY; CHILD; FEMALE; GENETICS; GERMLINE MUTATION; HYPERALDOSTERONISM; MALE; METABOLISM; MOLECULAR GENETICS; MUTATION; PEDIGREE; PRESCHOOL CHILD; PROTEIN CONFORMATION; SEQUENCE ALIGNMENT;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL ADENOMA; ALDOSTERONE; AMINO ACID SEQUENCE; CALCIUM CHANNELS, L-TYPE; CELL LINE; CHILD; CHILD, PRESCHOOL; FEMALE; GERM-LINE MUTATION; HUMANS; HYPERALDOSTERONISM; MALE; MOLECULAR SEQUENCE DATA; MUTATION; PEDIGREE; PROTEIN CONFORMATION; SEQUENCE ALIGNMENT;

EID: 84883464824     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.2695     Document Type: Article

References (28)

1. Choi, M. et al. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331, 768-772 (2011).
2. Spät, A. & Hunyady, L. Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol. Rev. 84, 489-539 (2004).
3. Rossi, G.P. et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J. Am. Coll. Cardiol. 48, 2293-2300 (2006).
4. Conn, J.W. Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome. J. Lab. Clin. Med. 45, 3-17 (1955).
5. Scholl, U.I. et al. Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5. Proc. Natl. Acad. Sci. USA 109, 2533-2538 (2012).
6. Tadjine, M., Lampron, A., Ouadi, L. & Bourdeau, I. Frequent mutations of β-catenin gene in sporadic secreting adrenocortical adenomas. Clin. Endocrinol. 68, 264-270 (2008).
7. Catterall, W.A. Signaling complexes of voltage-gated sodium and calcium channels. Neurosci. Lett. 486, 107-116 (2010).
8. Baig, S.M. et al. Loss of Cav1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness. Nat. Neurosci. 14, 77-84 (2011).
9. Hu, C., Rusin, C.G., Tan, Z., Guagliardo, N.A. & Barrett, P.Q. Zona glomerulosa cells of the mouse adrenal cortex are intrinsic electrical oscillators. J. Clin. Invest. 122, 2046-2053 (2012).
10. Tadross, M.R., Ben Johny, M. & Yue, D.T. Molecular endpoints of Ca2+/calmodulin- and voltage-dependent inactivation of Cav1.3 channels. J. Gen. Physiol. 135, 197-215 (2010).
11. Clark, V.E. et al. Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1 and SMO. Science 339, 1077-1080 (2013).
12. Platzer, J. et al. Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels. Cell 102, 89-97 (2000).
13. Hering, S. et al. Pore stability and gating in voltage-activated calcium channels. Channels 2, 61-69 (2008).
14. Hoda, J.C., Zaghetto, F., Koschak, A. & Striessnig, J. Congenital stationary night blindness type 2 mutations S229P, G369D, L1068P, and W1440X alter channel gating or functional expression of Cav1.4 L-type Ca2+ channels. J. Neurosci. 25, 252-259 (2005).
15. Hemara-Wahanui, A. et al. A CACNA1F mutation identified in an X-linked retinal disorder shifts the voltage dependence of Cav1.4 channel activation. Proc. Natl. Acad. Sci. USA 102, 7553-7558 (2005).
16. Splawski, I. et al. Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc. Natl. Acad. Sci. USA 102, 8089-8096 (2005).
17. Hans, M. et al. Functional consequences of mutations in the human α1A calcium channel subunit linked to familial hemiplegic migraine. J. Neurosci. 19, 1610-1619 (1999).
18. Battistini, S. et al. A new CACNA1A gene mutation in acetazolamide- responsive familial hemiplegic migraine and ataxia. Neurology 53, 38-43 (1999).
19. Scholl, U.I. & Lifton, R.P. New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5. Curr. Opin. Nephrol. Hypertens. 22, 141-147 (2013).
20. Beuschlein, F. et al. Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nat. Genet. 45, 440-444 (2013).
21. Kang, S. et al. Cav1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson's disease. Nat. Commun. 3, 1146 (2012).
22. Peloquin, J.B., Rehak, R., Doering, C.J. & McRory, J.E. Functional analysis of congenital stationary night blindness type-2 CACNA1F mutations F742C, G1007R, and R1049W. Neuroscience 150, 335-345 (2007).
23. Ducros, A. et al. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N. Engl. J. Med. 345, 17-24 (2001).
24. Brenner, C.H. A note on paternity computation in cases lacking a mother. Transfusion 33, 51-54 (1993).
25. Butler, J.M., Schoske, R., Vallone, P.M., Redman, J.W. & Kline, M.C. Allele frequencies for 15 autosomal STR loci on U.S. Caucasian, African American, and Hispanic populations. J. Forensic Sci. 48, 908-911 (2003).
26. Gonzalez-Gutierrez, G. et al. The guanylate kinase domain of the β-subunit of voltage-gated calcium channels suffices to modulate gating. Proc. Natl. Acad. Sci. USA 105, 14198-14203 (2008).
27. Marcantoni, A. et al. Loss of Cav1.3 channels reveals the critical role of L-type and BK channel coupling in pacemaking mouse adrenal chromaffin cells. J. Neurosci. 30, 491-504 (2010).
28. Roberts-Crowley, M.L. & Rittenhouse, A.R. Arachidonic acid inhibition of L-type calcium (Cav1.3b) channels varies with accessory Cavß subunits. J. Gen. Physiol. 133, 387-403 (2009).